TrialNature communications2022

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.

Yongxian Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.